Roche Holding AG
RO
Rang in aandelen
#43
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aandeelprijs
$514.50
Marktkapitalisatie
$349.98B
Verandering (1 dag)
2.59%
Verandering (1 jaar)
38.12%
Land
CH
Handel Roche Holding AG (RO)
Categorie
Healthcare
P/S-ratio voor Roche Holding AG (RO)
P/S-ratio op February 2026 TTM: 4.66
Volgens de meest recente financiële rapporten en aandelenkoers van Roche Holding AG is de huidige P/S-ratio (TTM) 4.66. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Roche Holding AG van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| Niet genoeg gegevens voor de verstrekte datums. | ||
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| 14.32 | 207.41% |
US
|
|
| 6.16 | 32.23% |
US
|
|
| 7.78 | 67.02% |
US
|
|
| 5.48 | 17.67% |
US
|
|
| 5.52 | 18.51% |
CH
|
